Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.
Clinical trial NCT04460911 · COMPLETED
Trial details
- NCT number
- NCT04460911
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-19
- Primary completion
- 2022-04-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.